Barclays’s Argan AGX Stock Holding History

Barclays’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$799K	Buy	+1,000	New	+$665K	﹤0.01%	2932

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Barclays's AGX Position: Q2 2026 in Review

Barclays reduced its Argan (AGX) stake by 17% in Q2 2026, selling an estimated $488K and leaving 3,566 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Barclays first reported a position in AGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.64M in Q2 2025. 566 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Barclays held 3,566 shares of Argan worth $2.85M as of Q2 2026.
Barclays sold 734 Argan shares in Q2 2026, an estimated $488K.
Argan made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2156 holding.
Barclays first reported a position in Argan in Q2 2013 and has held it in 52 quarters since.
Barclays's Argan position peaked at $8.64M in Q2 2025.
566 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.